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Abstract
Physiological erythrocyte removal is associated with a selective increase in expression of neoantigens on erythrocytes and
their vesicles, and subsequent autologous antibody binding and phagocytosis. Chronic erythrocyte transfusion often leads
to immunization and the formation of alloantibodies and autoantibodies. We investigated whether erythrocyte storage
leads to the increased expression of non-physiological antigens. Immunoprecipitations were performed with erythrocytes
and vesicles from blood bank erythrocyte concentrates of increasing storage periods, using patient plasma containing
erythrocyte autoantibodies. Immunoprecipitate composition was identified using proteomics. Patient plasma antibody
binding increased with erythrocyte storage time, while the opposite was observed for healthy volunteer plasma, showing
that pathology-associated antigenicity changes during erythrocyte storage. Several membrane proteins were identified as
candidate antigens. The protein complexes that were precipitated by the patient antibodies in erythrocytes were different
from the ones in the vesicles formed during erythrocyte storage, indicating that the storage-associated vesicles have a
different immunization potential. Soluble immune mediators including complement factors were present in the patient
plasma immunoprecipitates, but not in the allogeneic control immunoprecipitates. The results support the theory that
disturbed erythrocyte aging during storage of erythrocyte concentrates contributes to transfusion-induced alloantibody
and autoantibody formation.
Citation: Dinkla S, Novotny´ VMJ, Joosten I, Bosman GJCGM (2012) Storage-Induced Changes in Erythrocyte Membrane Proteins Promote Recognition by
Autoantibodies. PLoS ONE 7(8): e42250. doi:10.1371/journal.pone.0042250
Editor: Ivan Cruz Moura, Institut national de la sante´ et de la recherche me´dicale (INSERM), France
Received January 4, 2012; Accepted July 5, 2012; Published August 3, 2012
Copyright:  2012 Dinkla et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: G.Bosman@ncmls.ru.nl
Introduction
Physiological, age-dependent removal of erythrocytes is an
efficient and well-regulated process, consisting of controlled
exposure of molecules that induce recognition of old erythrocytes
by the immune system. This process includes senescent cell antigen
formation on band 3, possibly in combination with phosphatidyl-
serine (PS) exposure on the outer leaflet of the membrane and/or
decreased CD47 expression, ultimately resulting in binding of
autologous IgG and subsequent phagocytosis by macrophages of
the reticulo-endothelial system. [1] During aging, the erythrocyte
produces numerous vesicles, most of which expose PS, and that
are enriched for IgG and age-related band 3 breakdown products.
These vesicles are rapidly removed from the circulation, probably
by the same mechanism that is responsible for erythrocyte
removal. Vesiculation may constitute a protective mechanism to
prevent untimely erythrocyte removal [2].
A clear picture of the molecular mechanisms involved in this
age-dependent increase in removal signals is gradually emerging,
and involves oxidative damage-induced, high-affinity binding of
hemoglobin to band 3, activation of Ca2+-permeable channels,
phosphorylation-controlled loss of metabolism and structure, and
degradation and/or aggregation of band 3 fragments. However,
the molecular details, triggers and cross-talk between these
pathways are largely unknown [1].
Also, the erythrocyte contains a complex set of regulatory
systems that may induce erythrocyte removal after physiological or
pathological injury such as osmotic shock, oxidative stress and/or
energy depletion. [3] Modulation of these pathways becomes
progressively lost during storage, [4,5] and this may result in
accelerated aging and the removal of up to 30% of the transfused
erythrocytes within 24 hours after transfusion. [6] Disruption of
these systems may trigger aberrant expression of pathogenic
epitopes on stored erythrocytes and their vesicles [7].
Frequent erythrocyte transfusions can lead to immunization and
the formation of alloantibodies. This is especially problematic in
the steadily increasing number of transfusion-dependent patients.
Almost half of these patients acquire alloantibodies at some point
in time, and in approximately 10% of the patients erythrocyte
autoantibodies are detected. Part of the patients that produce these
autoantibodies develop autoimmune hemolytic anemia (AIHA),
which can be life-threatening [8].
We postulated that accelerated and/or altered erythrocyte aging
during blood bank storage leads to the formation of non-
physiological neoantigens that trigger the formation of autoanti-
bodies. In order to test this hypothesis, we performed immuno-
precipitations with erythrocytes and vesicles from blood bank
concentrates of increasing storage periods, using plasma from
patients containing erythrocyte autoantibodies. Subsequently,
immunochemical and proteomic techniques were applied to
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identify the captured immune complexes. Our findings strengthen
and deepen the view that disturbed erythrocyte aging during
storage is related to transfusion-induced, anti-erythrocyte antibody
formation.
Materials and Methods
Ethics
The study has been approved by the Committee on Research
involving Human Subjects (CMO) of the Radboud University
Medical Center (‘‘Instituut Waarborging kwaliteit en veiligheid/
Commissie Mensgebonden onderzoek regio- Arnhem-Nijmegen’’)
and in accordance with the declaration of Helsinki. Written
informed consent was obtained from all blood donors participating
in this study.
Patients and Healthy Volunteers
Plasma samples from nine patients with a positive direct
antiglobulin test (DAT) and confirmed erythrocyte autoantibodies
were included in this study. Four patients were diagnosed with
AIHA. One of these patients presented with AIHA after which a
relapse acute myeloid leukemia was observed, while another was
diagnosed with having both AIHA and anti-phospholipid
syndrome. Two additional patients were diagnosed with immune
thrombocytopenia and AIHA (Evans syndrome). Three patients
with detectable erythrocyte autoantibodies without any clinical
consequences was included as well (Table 1). The antibodies of
one patient reacted with the erythrocyte Rhesus e-antigen on the
patient’s autologous erythrocytes. In five patients anti-Wrighta
(Wra) antibodies were detected, and in one patient additional anti-
Cw antibodies were present. Cold reactive autoantibodies were not
detected in any of the samples. Allogeneic plasma from healthy
volunteer blood donors was used as a control. All plasma samples
used in this study had been stored at 220uC before use.
Isolation and Storage of Erythrocytes
An erythrocyte concentrate was obtained using standard blood
bank procedures, from a single eligible donor who was AB0,
Rhesus, Wra and Cw compatible for the detected antibodies in the
patient plasmas. Whole blood (500 ml) was collected in a
Composelect quadruple CPD-SAGM top-and-bottom bag system
(Fresenius Kabi, Bad Homburg, Germany), containing 70 ml
CPD as an anticoagulant. After cooling and centrifugation,
erythrocytes were isolated using a Compomat G4 (Fresenius
Kabi, Bad Homburg, Germany), after which 110 ml SAG-M was
added to the erythrocytes. The erythrocyte suspension was
leukocyte-depleted by in-line filtration, and subsequently stored
at 2 to 6uC.
Sampling of Erythrocyte Concentrates
During a storage period of 35 days, this erythrocyte concentrate
was sampled at regular intervals. After sampling, erythrocytes were
isolated by 10 min centrifugation at 1500 g. At the time of blood
collection, an additional EDTA tube of whole blood was collected
for isolation of plasma and fresh erythrocytes using a Ficoll
gradient.
Isolation of Erythrocyte Vesicles
Erythrocyte-derived vesicles were obtained from 35 day-old
erythrocyte concentrates of two donors who were AB0, Rhesus
and Wra compatible for the detected antibodies in the patient
plasmas. The concentrates were centrifuged for 10 min at 1500 g
to remove all cells. Membrane debris was then removed from the
supernatant by centrifugation for 20 min at 1500 g. Vesicles were
isolated by centrifuging 1.4 ml aliquots of supernatant for 20 min
at 21,000 g. All but 25 ml of the supernatant was then removed,
and the vesicle pellet was resuspended and stored at 280uC.
Indirect Immunoprecipitation of Erythrocyte
Autoantigens
Immunoprecipitation was performed using a modified version
of the procedure described by Barker and colleagues. [9]
Erythrocytes (1.56109) were washed three times using incomplete
Ringer (IR) solution (32 mM HEPES, 125 mM NaCl, 5 mM
glucose, 5 mM KCl, 1 mM MgSO4, pH 7.4), before incubation
for 1 h at 37uC with 500 ml plasma diluted 1/1 in IR. The
sensitized erythrocytes were then washed three times with IR, and
lysed by adding lysis buffer (10 mM HEPES, 1 mM EDTA,
1 mM EGTA, 1 mM benzamidin, 5 mM leupeptin, pH 8.0). The
erythrocyte membranes were pelleted by centrifugation at
21,000 g for 10 min and washed multiple times with lysis buffer
to remove hemoglobin. The membranes were dissolved in 200 ml
1% TX-100 buffer (25 mM HEPES, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1 mM benzamidin, 5 mM leupeptin, pH
7.4) or RIPA buffer (1% NP-40, 1% deoxycholate, 0.1% SDS,
25 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1 mM benzamidin, 5 mM leupeptin, pH 7.4) for 30 min on ice
with regular vortexing. Unless mentioned otherwise, the TX100
Table 1. Summary of patient information.
Patient Clinical diagnosis Blood group DAT IAT Alloantibody Autoantibody
1 AIHA (AML) 0 cc d ee IgG, C3 1:4 anti-Wra NS
2 Evans syndrome 0 cc d ee IgG 1:8 2 NS
3 AIHA (APLS) AB CC D ee IgG, C3 1:1 anti-Wra NS
4 2 A CC D ee IgG 1:1 anti-Wra, -Cw NS, anti-e
5 AIHA A Cc D Ee IgG, C3 1:1 anti-Wra NS
6 AIHA A Cc D ee IgG 1:4 anti-Wra NS
7 Evans syndrome 0 Cc D ee IgG 1:1 2 NS
8 2 0 Cc D ee IgG 1:1 2 NS
9 2 0 cc d ee IgG, C3 1:1 2 NS
DAT = direct antiglobulin test, IAT = indirect antiglobulin test (bovine) titer, AIHA = autoimmune hemolytic anemia, AML = acute myeloid leukemia, NS = non-
specific, APLS = antiphospholipid syndrome. All patients had a positive DAT and IAT.
doi:10.1371/journal.pone.0042250.t001
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buffer was applied. Insoluble cytoskeletal components were
removed by 15 min centrifugation at 21,000 g. The protein
content of the supernatant was determined using the Bradford
assay. [10] Supernatant (250 ml) containing 0.35 mg protein was
incubated with 50 ml protein G Dynabeads (Invitrogen, Carlsbad,
USA) for 16 h at 4uC to capture immune complexes. The beads
were washed three times with 1% TX-100 buffer or RIPA buffer
prior to, and directly after the incubation with the supernatant.
Then the captured proteins were dissociated in 15 ml Laemmli
sample buffer (BioRad, Hercules, USA) containing 5% 2-
mercaptoethanol for 30 min at 37uC. When non-denaturing
conditions were applied, proteins were eluted using 50 mM
glycine pH 2.8 for 5 min at room temperature, after which sample
buffer was added (1/4 ratio) without 2-mercaptoethanol. Samples
were stored at 280uC, and thawed on ice on the day of analysis.
Immunoprecipitation of erythrocyte vesicles was performed using
the same protocol without the lysis step, using a single vesicle
aliquot per sample. Smaller (100 ml) incubation volumes were used
for vesicle opsonization, membrane dissolution and immune
complex capture. Plasma was depleted of vesicles by centrifugation
for 60 min at 21,000 g before being used to opsonize erythrocyte
vesicles. Subsequent erythrocyte vesicle isolation and washing was
performed by centrifugation for 20 min at 21,000 g. Direct anti-
band 3 immunoprecipitation in vesicles was performed using
protein G Dynabeads, opsonized with a mouse monoclonal
antibody that recognizes an N-terminal epitope of band 3 (BIII-
136, Sigma-Aldrich, St. Louis, USA), diluted 1:20 in 200 ml
phosphate-buffered saline (PBS), pH 7.4. In the immunoprecip-
itation experiments we observed 25–30 and 50–60 kDa bands,
representing the light and heavy chains of the bound antibodies,
respectively.
SDS-PAGE
SDS-PAGE was performed using TGX 4–15% gels in the Mini
Protean 3 system (both BioRad, Hercules, USA). [11] Approxi-
mate molecular masses were calculated based on the Precision Plus
Protein Standard (BioRad, Hercules, USA). Following SDS-PAGE
(12.5 ml sample per lane), the gels were either used for
immunoblotting, or developed using a silver stain. [12] Optical
densities (OD) of the protein bands were determined using the GS
690 imaging densitometer (Bio-Rad, Hercules, USA) in combina-
tion with Molecular Analyst version 1.5 software. Total erythro-
cyte membrane fractions were loaded as positive controls and for
normalization purposes.
Erythrocyte Vesicle Membrane Protein Biotinylation
For immunoblotting, vesicle membrane proteins were biotiny-
lated prior to IP. Vesicles were washed once with PBS pH 7.4, and
labeled with 1 mM sulfo-NHS-biotin (Thermo Fisher, Waltham,
USA) in PBS pH 8.0 for 30 min at 4uC. Residual sulfo-NHS-
biotin was removed by two consecutive washing steps with PBS
pH 7.4 containing 100 mM glycine.
Immunoblotting
After SDS-PAGE, the proteins were transferred to PVDF
membranes using the iBlot system (Invitrogen, Carlsbad, USA).
The membranes were then blocked with Odyssey Blocking Buffer
(OBB, LI-COR, Lincoln, USA), and incubated for 16 h at 4uC in
OBB containing 0.1% Tween-20 and 1/1000 rabbit polyclonal
antiserum against the membrane domain of human band 3
(K2N6B/PMB3, [13]). After three washing steps with PBS
containing 0.1% Tween-20, the blots were incubated for 1 h at
room temperature in OBB, 0.1% Tween-20, 0.01% SDS, 1/
10,000 streptavidin-Alexa Fluor 680 (Invitrogen, Carlsbad, USA),
and 1/10,000 goat anti-rabbit IgG-IRDye 800 (LI-COR, Lincoln,
USA). This final incubation was followed by a single washing step
using PBS containing 0.1% Tween-20, and three subsequent
washes with PBS. Immunoblots were scanned using the Odyssey
Infrared Imaging System (LI-COR, Lincoln, USA), and analyzed
using Odyssey Software version 2.1.
Proteomics
After one-dimensional gel electrophoresis and blue silver
staining, [14] protein bands of interest were excised and submitted
to in-slice tryptic digestion. In case of total protein identification,
the sample was run briefly into the gel, after which the entire
product was excised and digested. Peptide sequencing of tryptic
digests was performed by nano-liquid chromatography tandem
mass spectrometry using the LTQ-FT ICR (Thermo Fisher,
Waltham, USA) mass spectrometer essentially as described
previously. [15] Peptide and protein identifications were extracted
with the Mascot search engine version 2.2, using the Reference
Sequence (RefSeq) database at the National Center for Biotech-
nical Information (NCBI) with Homo sapiens taxonomy and
added sequence-tags. Carbamidomethylation of cysteines (fixed),
oxidation of methionine (variable) and acetylation of the N-
terminus (variable) were the modifications allowed in the search.
Protein identification validation was performed by an in-house
developed script. [15] The software classifies protein identifica-
tions based on the number of uniquely identified peptide
sequences, clusters proteins sharing the same set of peptides, and
validates the proteins with the following criteria: proteins with a
single peptide must have a peptide score of .49, proteins with
multiple peptides must have a score of .29.
Statistical Analysis
Differences between the patient and allogeneic control group
were determined using a two-way ANOVA followed by a
Bonferroni post test. Differences within a single group were
determined using a one-way ANOVA followed by a Tukey post
test. A confidence level of p,0.05 was considered to be significant.
Results
Altered Epitope Expression of Erythrocytes during Blood
Bank Storage
Storage lesions, possibly resulting in accelerated aging, are
responsible for the fast removal of a considerable portion of the
erythrocytes after transfusion. Both non-physiological aging and
enhanced removal are likely to contribute to the antibody
responses against erythrocytes frequently observed in chronically
transfused patients. In order to test the hypothesis that storage of
erythrocytes under blood bank conditions leads to the formation of
non-physiological neoantigens, a modified indirect immunopre-
cipitation was performed using plasma of six patients with
erythrocyte autoantibodies (Table 1) or of healthy donors (see
Materials and Methods), in combination with erythrocytes
sampled at different time points from a stored erythrocyte unit.
Immunoprecipitations were performed at regular intervals during
blood bank storage.
All plasmas tested precipitated proteins in the 90 to 100 kDa
range (Figure 1). Immunoprecipitation using Ringer buffer instead
of plasma did not result in any detectable protein precipitation
(Figure 1A). Our data show that, although protein quantification
of complex protein mixtures using silver staining can be
problematic due to a limited dynamic range of the technique,
[16] silver staining proved to work well with the highly purified
immunoprecipitates we obtained (Figure 1A). Both the patient and
Erythrocyte Storage Promotes Autoantibody Binding
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the allogeneic control plasmas showed a decrease in signal after
the first week of erythrocyte storage. In contrast to the control
samples that revealed a further significant decrease in signal with
time, the signals derived from patient plasma significantly
increased again with storage time (Figure 1B). Immunoblot
analysis of membrane fractions from erythrocytes of various
storage periods using patient and allogeneic control plasma
resulted in high background signals and/or non-specific binding,
probably due to the denaturing conditions of SDS-PAGE and
blotting (data not shown).
Freshly stored erythrocytes are recognized by naturally occur-
ring antibodies. [1] At the later stages of storage, only autoanti-
bodies present in the patient plasmas show enhanced binding to
erythrocytes, suggesting a change in erythrocyte make-up upon
storage that is only detectable with patient plasma. This change
may be a trigger for pathological events. In order to determine the
identity of the protein(s) involved, we proceeded to analyze the
precipitated proteins by proteomics.
Identity of the Precipitated Proteins
In addition to the proteins in the 90 to 100 kDa range,
immunoprecipitation of erythrocyte membrane fractions using
patient plasmas revealed multiple other protein bands (Figure 2A).
Differential extraction experiments showed that the proteins in the
90 to 100 kDa range were directly targeted by the patient plasma,
instead of being co-precipitated as was the case for several other
proteins, such as the 80 kDa protein band, which dissociated from
the immune complex under the more stringent conditions of the
RIPA buffer (Figure 2A). Furthermore, SDS-PAGE under non-
reducing conditions indicated that the precipitated proteins mostly
reside in one or more large complexes (Figure 2A). Heavy and
light antibody chains (H and L in Figure 2A) are clearly visible due
to the nature of the technique used.
For proteomics analysis, an immunoprecipitation using patient
plasma (patients 1, 8 and 9) and allogeneic plasma (control) was
performed in triplicate on erythrocytes stored for 35 days. A
representative silver stained gel of one of these immunoprecipi-
tations is depicted in Figure 2B. The total products of these
immunoprecipitations were analyzed by mass spectrometry
(Table 2). In addition, gel slices in the 80–100 and 70–80 kDa
ranges (Figure 2B, slices I and II, respectively) were excised from
the immunoprecipitation product of the erythrocytes incubated
with the plasma of patient 1 and analyzed by proteomics.
In summary, the proteomic analysis revealed that erythrocyte
autoantibodies from the patient plasma precipitate multiple
proteins. The samples consisted of membrane as well as cytosolic
proteins, all of which have been described in previous proteomic
inventories of the erythrocyte membrane (Table 2). [17] Further-
more they contained various plasma proteins, such as immuno-
globulins, complement components, lipoproteins, and several
immunoglobulins, and complement and coagulation-associated
proteins. The protein compositionof the samples from the different
patient samples revealed significant overlap, although less proteins
were detected in the samples of patients 8 and 9. This could be due
to the lower titer of these plasmas (Table 1). Proteomic analysis of
the allogeneic plasma control precipitation did not reveal any
erythrocyte-related proteins.
A complete list of all the proteins detected in the proteomics
analysis is provided in Table S1.
Finally, we attempted to elucidate the nature of the most
dominant antigens. The proteomic analysis of gel slice I (Figure 2B)
identified several proteins, including band 3 as the only membrane
protein detected (Table S1).
Erythrocyte Autoantibodies Recognize Erythrocyte
Vesicles Formed during Blood Banking
During their stay in the circulation, erythrocytes form vesicles
that are rapidly removed once they appear in the bloodstream.
Vesiculation also occurs during blood banking, especially during
the later stages of storage. [18] Since erythrocyte vesiculation
in vivo may constitute a mechanism for the removal of damaged
membrane patches, and these vesicles are efficiently opsonized,
[2,15] we investigated whether vesicles formed during blood bank
storage were also recognized by patient anti-erythrocyte antibod-
ies.
We performed immunoprecipitations using patient plasma and
biotinylated erythrocyte vesicles isolated from 35 day old eryth-
rocyte concentrates (see Materials and Methods). These precipi-
tates were then visualized by immunoblotting for biotinylated
membrane proteins.In stored erythrocyte vesicles, multiple pro-
teins were targeted by the patient anti-erythrocyte antibodies,
including the proteins in the 90 to 100 kDa range also observed in
the erythrocyte precipitates (Figure 3A).
Figure 1. Erythrocyte autoantibody immunoprecipitation of
erythrocytes sampled at regular time intervals during storage.
Analysis was performed by SDS-PAGE, followed by silver staining. (A)
Protein patterns of precipitates obtained using Ringer, autologous
plasma, and a representative example from one out of three allogeneic
plasmas, and one out of six autoantibody-containing plasmas (patient
No. 2). For the allogeneic controls, day 14 is missing. (B) Mean optical
density (OD) of patient (N, solid line, N= 6 patients) and allogeneic
control plasma (m, dotted line, N = 3 volunteers) precipitations.
Numbers indicate approximate molecular weight (kDa). Error bars
represent standard error, *p,0.05.
doi:10.1371/journal.pone.0042250.g001
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In order to identify the protein content of the targeted complex
in these vesicles, an immunoprecipitation was performed in
triplicate on vesicles obtained from a 35 day-old transfusion unit
and analyzed by mass spectrometry (Table 2). An immunoblot of
the immunoprecipitate is depicted in Figure 3B. In addition, we
identified the proteins in a 240–320 kDa gel slice from the
immunoprecipitation (Figure 3B, slice III and Table S1). A
comparison of the erythrocyte to the vesicle precipitate shows a
large overlap in their protein contents, including the presence of
band 3. However, some clear differences were observed as well.
Most notable are the absence of ankyrin and spectrin in the
erythrocyte complex, and the absence of adducin in the vesicle
complex (Table 2). In the vesicle immunoprecipitation, comple-
ment and lipoprotein peptides were much more abundant than in
the erythrocyte immunoprecipitations (Table 2 and Table S1).
Since band 3 was found to be part of the vesicle-derived
precipitates, immunoprecipitations using either patient plasma or
a monoclonal anti-band 3 antibody and biotinylated erythrocyte
vesicles were performed as well (Figure 3A). These precipitates
were then visualized by immunoblotting for biotinylated mem-
brane proteins and band 3. The latter immunoprecipitation
revealed a biotinylated protein pattern that is different from that
obtained with the patient plasma, indicating that different proteins
were targeted (Figure 3A). Although band 3 staining of the patient
sample immunoblot using a polyclonal anti-band 3 antiserum did
not detect full-length band 3 (Figure 3A), several band 3
breakdown products that form during erythrocyte aging and
storage were observed [1,15].
Discussion
During storage under blood bank conditions, erythrocytes
undergo a number of functional and structural alterations, known
as storage lesions. An accelerated and/or disturbed cellular aging
process is likely to trigger aberrant expression of removal signals,
thereby contributing to the removal of up to 30% of the
erythrocytes within the first 24 hours after transfusion. This may
contribute to the immunologic responses associated especially with
chronic transfusions [1,8].
Here we show that the main targets of the erythrocyte
autoantibody-containing patient plasmas tested in this study are
proteins in the 90 to 100 kDa range, which proteomic analysis
revealed to include the membrane protein band 3. Band 3 is
known to form three distinct complexes with other membrane and
cytosolic proteins, and is the membrane anchorage site for the
erythrocyte cytoskeleton. [19] Proteomic analysis showed that the
band 3 binding partners adducin, ankyrin, band 4.1, band 4.2,
GAPDH, hemoglobin and carbonic anhydrase were part of the
precipitated immune complex, which suggests that band 3
complexes were indeed recognized. Although other candidate
Figure 2. Erythrocyte autoantibody immunoprecipitation of stored erythrocytes. (A) Immunoprecipitation of 35 day old erythrocytes with
erythrocyte autoantibody-containing patient plasma and allogeneic control plasma, using TX100 or RIPA extraction buffer and analyzed by SDS-PAGE
under reducing or non-reducing conditions, followed by silver staining. A representative result (patient No. 2) from one out of three patient plasmas
is shown. (B) Example of a silver stained gel of an immunoprecipitation of 35 day stored erythrocytes with plasma of patient No. 1. The same sample
was used for Coomassie blue gel staining and subsequent proteomics analysis (Table 2). Gel slices which were excised for proteomic analyses are
indicated as slices I and II (see also Table S1). Numbers indicate molecular weight (kDa). Heavy [H] and light [L] antibody chains are indicated by
arrows.
doi:10.1371/journal.pone.0042250.g002
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Table 2. Summary of proteins identified by proteomics analyses of erythrocyte/vesicle immunoprecipitations using erythrocyte
autoantibody-containing plasma of patients 1, 8 and 9, and allogeneic plasma (control).
MW Erythrocyte Vesicle
Protein (kDa) Control Patient 1 Patient 8 Patient 9 Patient 1
Structural
Band 3 95 + + +
Band 4.1 66 + + +
Band 4.2 80 + +
Adducin 81 + +
Ankyrin 206 +
Actin 42 + + + +
Spectrin 246 +
Metabolism
GAPDH 36 + +
Glucose transporter 1 54 + +
Glutathione S-transferase 26 +
Phosphofructokinase 85
Type II PIP kinase 46 +
Various
a globin 15 + +
b globin 16 + + + +
Annexin II 39 +
Carbonic anhydrase I 29 +
Carbonic anhydrase II 29 + +
HSP 70 70 +
Stomatin 32 + +
Thioredoxin 12 +
Thrombospondin 1 129 +
Transglutaminase 3 77
Immunoglobulins
Ig heavy chain 50–60 + +
Ig light chain 25–30 + +
Complement
CC 1 26 + + +
CC 3 187 + + + +
CC 4 193 + + + + +
CC 5 188 + + + +
CC 6 105 +
CC 8 22 + +
CC 9 63 +
Factor B 90 + +
Complement inhibitors
C1 inhibitor + +
Clusterin 58 + + + +
Factor H 155 + +
Inter-a inhibitor 101–107 + + + +
Vitronectin 54 +
Lipoproteins
Apolipoprotein A 31 + + + +
Apolipoprotein B 516 + + + + +
Apolipoprotein D 21 +
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antigens cannot be completely ruled out, the observation that band
3 is the only membrane protein detected in the immunoprecip-
itates, makes it the most likely candidate antigen. Band 3 likely
contains epitopes that trigger the harmful immune response
leading to the formation of these erythrocyte autoantibodies. [20]
This is underscored by the ability of a band 3 peptide to prime T
cells for a band 3 response and accelerate the development of
erythrocyte autoantibodies and anemia in a mouse model for
AIHA [21].
Our data reveal that autologous and allogeneic plasma
predominantly reacted with fresh and short stored erythrocytes,
possibly by the binding of naturally occurring anti-band 3
antibodies. [1] In contrast, patient plasma autoantibody binding
increased during erythrocyte storage, which suggests that non-
physiological antigens become expressed during blood bank
storage. One explanation for the enhanced autoantibody binding
could be storage lesion-induced expression of erythrocyte aging-
associated antigens [1,4,5].
Notably, previous work on erythrocyte autoantibodies, showed
these antibodies to be specific for either band 3 or Rhesus protein.
[9,20] The apparent absence of Rhesus proteins in our analyses is
probably due to the exclusion of patient plasma that showed
(partial) specificity toward Rhesus antigens. The presence of
alloantibodies against Wra, an epitope located on band 3, [22] in
five of the nine patients also hints at specificity for band 3 rather
than Rhesus protein.
A remarkable observation was the precipitation of adaptor
protein 2 (AP2) complex by the patient plasma (Table S1), as this
protein is responsible for membrane attachment of, and
membrane protein recruitment to clathrin-coated vesicles. [23]
AP2 might be a remnant from the reticulocyte stage that binds to
one or more proteins in the precipitated complex. Band 3 has been
shown to interact with clathrin-coated vesicle machinery in kidney
cells, which supports this possibility [24].
Although erythrocyte-derived vesicles formed during storage are
known to be enriched in immunoglobulins, [15,25] we here show
that anti-erythrocyte autoantibodies readily recognized the vesicles
as well. The vesicle precipitates contained spectrin and ankyrin,
while the erythrocyte precipitates did not. The opposite was
observed for adducin, which was present only in the erythrocyte
Figure 3. Erythrocyte autoantibody immunoprecipitation of biotinylated erythrocyte vesicles from a 35 day old transfusion unit.
(A) Immunoprecipitation with either plasma from patient No. 2, or a monoclonal antibody against band 3 (see Materials and Methods). Analysis was
performed by SDS-PAGE, followed by detection of biotinylated membrane proteins (red, streptavidin) and band 3 (green, polyclonal rabbit antibody).
A protein G bead control was included. (B) Example immunoprecipitation of biotinylated erythrocyte vesicles from a 35 day old transfusion unit using
plasma from patient No. 1. Analysis was performed by SDS-PAGE, followed by detection of biotinylated membrane proteins using fluorochrome
conjugated streptavidin. The same sample was used for Coomassie blue gel staining and subsequent proteomics analysis (Table 2). The gel slice
which was excised for proteomic analysis is indicated as slice III (see also Table S1). Numbers indicate approximate molecular weight (kDa). Blots were
analyzed using the Odyssey Infrared Imaging System.
doi:10.1371/journal.pone.0042250.g003
Table 2. Cont.
MW Erythrocyte Vesicle
Protein (kDa) Control Patient 1 Patient 8 Patient 9 Patient 1
Apolipoprotein E Apolipoprotein H 36 + + + + +
Apolipoprotein L1 44 +
doi:10.1371/journal.pone.0042250.t002
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precipitates. Ankyrin and adducin are known to reside in two
functionally different complexes in the erythrocyte membrane, the
ankyrin complex and the junctional complex. [19] An explanation
for our observations may be the selective erythrocyte autoantibody
binding of the band 3 - ankyrin complex in vesicles, compared to
the selective targeting of the junctional complex in erythrocytes.
The differences in protein composition between erythrocytes and
their vesicles could also account for the absence of adducin in the
vesicle precipitates. [2,15,18] The strikingly high complement
content and apparent presence of autoantigens in the patient
plasma vesicle precipitates indicate that these vesicles may be
involved in clinically relevant immune responses.
The possibility of selective recognition of damaged or degraded
band 3 in the vesicles was also investigated by comparing the
patient plasma immunoprecipitation to that of a monoclonal anti-
band 3 antibody. Patient erythrocyte autoantibodies appear to
recognize a subset of the band 3 complexes in the vesicles, as there
was only a partial overlap in the membrane proteins that were
precipitated. This fits with the known selective binding of
physiological autoantibodies to damaged band 3. [1,4] The
presence of damage-associated proteins (e.g. HSP70, 26S protea-
some and transglutaminases) and band 3 degradation products in
the complex precipitated using patient plasma supports this view
(Table S1, and Figure 3, respectively) [26,27].
Intriguingly, vesicle-associated spectrin was biotinylated using
the membrane-impermeable sulfo-NHS-biotin (Table S1, and
Figure 3C). One possible explanation is the diffusion of the sulfo-
NHS-biotin into damaged vesicles via membrane pores. [25]
Alternatively, the presence of inside-out oriented membrane
vesicles could explain the presence of biotinylated spectrin. [28]
The latter implies that, after erythrocyte transfusion, intracellular
epitopes become accessible to the immune system, [29] a process
generally known to be involved in the onset of autoimmune
disorders [30].
The alternative erythrocyte autoantibody targeting in these
vesicles, combined with the enhanced complement binding,
support the notion that erythrocyte-derived vesicles might be
important players in the inflammatory side-effects encountered
during and after chronic erythrocyte transfusion. [8,31] This is in
line with the increasing amount of evidence showing that vesicles
of different cellular origins are actively involved in inflamma-
tion.[32–34] Also, vesicle-containing supernatants from erythro-
cyte concentrates were found to have immune regulatory functions
[35,36].
Taken together, we have demonstrated a change in pathology-
associated erythrocyte antigenicity during blood bank storage,
which is accompanied with enhanced patient erythrocyte autoan-
tibody binding. These changes probably include storage-related
band 3 breakdown, as described in previous studies. [1,4] The
composition of the immune complex targeted in the vesicles was
different from that of stored erythrocytes, implying that the vesicles
might have a different capacity to modulate the immune system.
These findings corroborate the hypothesis that prolonged
storage increases the transfusion-associated risks, [37] in particular
the formation of anti-erythrocyte alloantibodies and autoantibod-
ies by transfusion-dependent patients. We aim to elucidate the
molecular identity of the involved epitopes, the mechanism(s)
underlying these changes, and their pathophysiological implica-
tions.
Supporting Information
Table S1 Proteins identified by proteomics analyses of
erythrocyte/vesicle immunoprecipitations using eryth-
rocyte autoantibody-containing plasma of patients 1, 8
and 9, and allogeneic plasma (control). Numbers represent
the identified peptide sequences per protein. Either total products
or gel slices containing proteins of a certain MW (kDa) were
analyzed. Proteins in specific gel slices were also identified (slices I
and II: Figure 2B, slice III: Figure 3B). Skin and trypsin
contaminants were excluded from this overview. Immunoprecip-
itations and proteomics analyses were performed as mentioned in
Materials and Methods.
(PDF)
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